A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1)

A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1)

It is now widely known that C-X3-C motif ligand 1 (CX3CL1) plays an essential part in the process of regulating pro-inflammatory cells migration across a wide range of inflammatory disorders, including a number of malignancies. However, there has been no comprehensive study on the correlation betwee...

Full description

Bibliographic Details
Main Author:	Yidi Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Genetics
Subjects:	chemokines CX3CL1 pan-cancer prognosis immune infiltration
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1183795/full

Similar Items

Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01)

The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic review
by: Mario A. Alarcón‐Sánchez, et al.
Published: (2024-02-01)

Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
by: CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
Published: (2023-12-01)

Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1‐CX3CR1 dependent manner and induce tumour cell apoptosis
by: Shuo Miao, et al.
Published: (2020-10-01)

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
by: Apoorvi Chaudhri, et al.
Published: (2023-09-01)

Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus
by: Amin Ullah, et al.
Published: (2023-10-01)

Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin therapy in Han patients with ovarian cancer
by: Xin-Chen Wang, et al.
Published: (2023-01-01)

Cochlear resident macrophage mediates development of ribbon synapses via CX3CR1/CX3CL1 axis
by: Xinyu Song, et al.
Published: (2022-11-01)

CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer
by: Xiangyang Liu, et al.
Published: (2024-04-01)

Anti-Inflammatory Effects of Allocryptopine via the Target on the CX3CL1–CX3CR1 axis/GNB5/AKT/NF-κB/Apoptosis in Dextran Sulfate-Induced Mice
by: Yang Yang, et al.
Published: (2023-02-01)

The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases
by: Matilda Iemmolo, et al.
Published: (2023-04-01)

CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting
by: Xueting Wang, et al.
Published: (2023-05-01)

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2023-08-01)

Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury
by: Qiming Gong, et al.
Published: (2023-10-01)

CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer’s Disease
by: Giulia Bivona, et al.
Published: (2023-05-01)

CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro
by: Xinzhe Feng, et al.
Published: (2023-08-01)

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
by: Valentina Marchica, et al.
Published: (2019-03-01)

The Interplay of Cx26, Cx32, Cx37, Cx40, Cx43, Cx45, and Panx1 in Inner-Ear Development of Yotari (dab1−/−) Mice and Humans
by: Josip Lesko, et al.
Published: (2022-03-01)

Inhibition of CX3CL1 by treadmill training prevents osteoclast-induced fibrocartilage complex resorption during TBI healing
by: Xiao Liu, et al.
Published: (2024-01-01)

Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1I249/M280-expressing retina
by: Kaira A. Church, et al.
Published: (2023-03-01)

Alteration of Cx37, Cx40, Cx43, Cx45, Panx1, and Renin Expression Patterns in Postnatal Kidneys of Dab1-/- (<i>yotari</i>) Mice
by: Mirela Lozić, et al.
Published: (2021-01-01)

Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200–CD200R and CX3CL1–CX3CR1 Systems
by: Katarzyna Chamera, et al.
Published: (2020-07-01)

Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice
by: Satoshi Mizutani, et al.
Published: (2021-05-01)

Berberine Suppresses Leukocyte Adherence by Downregulating CX3CL1 Expression and Shedding and ADAM10 in Lipopolysaccharide-Stimulated Vascular Endothelial Cells
by: Yi-Hong Wu, et al.
Published: (2022-04-01)

The Role of CX3CL1 and ADAM17 in Pathogenesis of Diffuse Parenchymal Lung Diseases
by: Jan Urban, et al.
Published: (2021-06-01)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
by: Paulina Pawelec, et al.
Published: (2020-10-01)

FRACTALKINE: PATHOGENIC ROLE AND DIAGNOSTIC CAPABILITIES
by: O. A. MESNYANKINA, et al.
Published: (2017-06-01)

Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells
by: Santosh Kumar Singh, et al.
Published: (2019-05-01)

Comparative Analysis of Cx31 and Cx43 in Differentiation-Competent Rodent Keratinocytes
by: Akina Au, et al.
Published: (2020-10-01)

Cytotoxin-Associated Gene A-Negative Helicobacter pylori Promotes Gastric Mucosal CX3CR1+CD4+ Effector Memory T Cell Recruitment in Mice
by: Heqiang Sun, et al.
Published: (2022-01-01)

CX3CL1(+) Microparticles-Induced MFG-E8 Enhances Apoptotic Cell Clearance by Alveolar Macrophages
by: Wen-Hui Tsai, et al.
Published: (2021-09-01)

CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM)
by: Anja Kathrin Wege, et al.
Published: (2021-05-01)

Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
by: Likun Cui, et al.
Published: (2023-10-01)

A double-edged sword: interactions of CX3CL1/CX3CR1 and gut microbiota in systemic lupus erythematosus
by: Rana A. Estaleen, et al.
Published: (2024-01-01)

Fractalkine Signalling (CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 Axis) as an Emerging Target in Coronary Artery Disease
by: Shu Xian Loh, et al.
Published: (2023-07-01)

Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance
by: Bashir Lawal, et al.
Published: (2021-08-01)

Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge
by: Thomas J. Powell, et al.
Published: (2022-12-01)

C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease
by: Albert Frank Magnusen, et al.
Published: (2021-11-01)

Mutation in the CX3C Motif of G Protein Disrupts Its Interaction with Heparan Sulfate: A Calorimetric, Spectroscopic, and Molecular Docking Study
by: Abu Hamza, et al.
Published: (2022-02-01)

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
by: Haosheng Zheng, et al.
Published: (2022-10-01)